A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer
Clinical trial NCT05699135 · TERMINATED
Trial details
- NCT number
- NCT05699135
- Sponsor
- Pfizer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-09
- Primary completion
- 2023-06-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.